4
Changes in Ownership
OptimizeRx Corp Filed Acc 0001628280-25-026500
Chief Commercial Officer acquired 9,483 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Greco Theresa Chief Commercial Officer | 2025-05-15 | Grant or award | +2,441 | 53,314 | D: show line 1 in the form | ||
| Greco Theresa Chief Commercial Officer | 2025-05-15 | Grant or award | +7,042 | 60,356 | D: show line 2 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Greco Theresa Chief Commercial Officer | 2025-05-15 | Grant or award · Stock Option | +12,133 | 12,133 | D: show line 3 in the form |
Loading xslF345X05/wk-form4_1747685039.xml…